发表文章
1.王兰,† 曾禧,† 姚后宗,* 袁涛*. 雪层杜鹃中的黄酮类化合物及其抗氧化和抗炎活性研究. 天然产物研究与开发 2024,
2.Wang, L.†; Zeng, X.†; Yuan T.*; Yao H. Z.*. Nivalones C–F, four new meroterpenoids from Rhododendron nivale. Fitoterapia 2024, 176, 106017.
3.Fang, J. J.†; Yao H. Z.†; Zhuang, C. L.*; Chen F. E*. Insight from linker investigations: Discovery of a novel phenylbenzothiazole necroptosis inhibitor targeting receptor-interacting protein kinase 1 (RIPK1) from a phenoxybenzothiazole compound with dual RIPK1/3 targeting activity. J. Med. Chem. 2023, 66, 15288-15308.
4.Zeng, Q. T.; Cui, H.; Yao, H. Z.*; Yuan T*. Five sesquiterpenes from Paraconiothyrium sp. and their anti-inflammatory activity. Chem. Biodiversity 2023, e202300477.
5.Deng, Z. Q.†; Yao, H. Z.† et al. and Zhu, G. Y. Platinum anticancer drugs: Targeting and delivery. In Bioinorganic Chemistry and Homogeneous Biomimetic Inorganic Catalysis; Pecoraro, V. L.; Guo, Z.; in Comprehensive Inorganic Chemistry III; Reedijk, J., Poeppelmeier, K. R., Eds.; Vol. 2, pp 808–846. Oxford: Elsevier. ©2023
6.Yao, H. Z. et al. and Zhu, G. Y. Enhancing Circulation and Tumor Accumulation of Carboplatin via an Erythrocyte‐Anchored Prodrug Strategy. Angew. Chem. Int. Ed. 2022, 61, e202203838.
7.Yao, H. Z. and Zhu, G. Y. Blood Components as Carriers for Small‐Molecule Platinum Anticancer Drugs. ChemMedChem. 2022, e202200482.
8.Yao, H. Z. and Zhu, G. Y. A platinum-based fluorescent “turn on” sensor to decipher the reduction of platinum (IV) prodrugs. Dalton Trans. 2022, 51, 5394-5398. (Front Cover)
9.Yao, H. Z. et al. and Zhu, G. Y. Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum (IV) anticancer prodrugs. Dalton Trans. 2021, 50, 13737−13747.
10.Yao, H. Z. et al. and Zhu, G. Y. BODI-Pt, a green-light-activatable and carboplatin-based platinum (iv) anticancer prodrug with enhanced activation and cytotoxicity. Inorg. Chem. 2020, 59, 11823−11833.
11.Yao, H. Z. et al. and Zhu, G. Y. Synthesis and cytotoxic study of a platinum (IV) anticancer prodrug with selectivity toward luteinizing hormone-releasing hormone (LHRH) receptor-positive cancer cells. Inorg. Chem. 2019, 58, 11076−11084.
12.Ni, S. J.†; Yao, H. Z.† et al. and Zhang, G. Chemical modifications of nucleic acid aptamers for therapeutic purposes. Int. J. Mol. Sci. 2017, 18, 1683.
13.Yao, H. Z. et al. and Zhang, G. Methods to design and synthesize antibody-drug conjugates (ADCs). Int. J. Mol. Sci. 2016, 17, 194.
14.Yao, H. Z. et al. and Qiao, C. H. Antischistosomal activity of N, N’-arylurea analogs against Schistosoma japonicum. Bioorg. Med. Chem. Lett. 2016, 26, 1386−1390.
15.姚后宗, 尹伟, 陈晶磊, 乔春华. 一种氟代丁酸腺苷衍生物的合成. 有机化学 2014, 34, 1222−1226.